Both in Pharmaceuticals
Anixa Biosciences vs NRX Pharmaceuticals
Over the past year ANIX returned −26.2% and NRXP returned −21.4%; their daily moves had a correlation of 0.19.
ANIX −26.2% NRXP −21.4%Growth of $1, one year, split-adjusted
| Metric | ANIX | NRXP |
|---|---|---|
| Price | $3.06 | $2.24 |
| Market cap | $106.2M | $97.0M |
| Today | +2.17% | +3.23% |
| 1 month | +3.6% | −22.0% |
| 6 months | +1.8% | −26.3% |
| Year to date | −2.1% | −17.3% |
| 1 year | −26.0% | −27.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 38.7% |
| Net margin | — | −1500.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 28.6× |
| Net cash | $13.9M | $26.3M |
| Dividend yield | — | — |
| Volatility (60d) | 58.8% | 57.2% |
| Short % of float | 7.4% | 29.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).